{"data":{"id":"us-mt/50-32-231","jurisdiction":"us-mt","citation":"50-32-231","heading":"Criteria for placement of drug in Schedule V.","body":"The board shall place a drug in Schedule V if it finds that:\n(1) the drug has low potential for abuse relative to the controlled drugs listed in Schedule IV;\n(2) the drug has currently accepted medical use in treatment in the United States; and\n(3) the drug has limited physical dependence or psychological dependence liability relative to the dangerous drugs listed in Schedule IV.","path":["TITLE 50. HEALTH AND SAFETY","CHAPTER 32. CONTROLLED SUBSTANCES","Part 2. Scheduling of Dangerous Drugs"],"source_url":"https://mca.legmt.gov/bills/mca/title_0500/chapter_0320/part_0020/section_0310/0500-0320-0020-0310.html","current_through":"Montana Code Annotated 2025","vintage":"","retrieved_at":"2026-09-14T04:56:24Z","sha256":"0fa52e0b0bea9a080e5a00a61822429f1904e043c107aad1f04549b9829d5d53","source_id":"us-mt","stale":false,"prev":"us-mt/50-32-230","next":"us-mt/50-32-232"},"notice":"GroundRules: Original legal text. Not legal advice."}